RxDoctor Payments Data

Charmille Hare, DO

Family Medicine · Locust Grove, GANPI 1114140704

Payments from drug & device makers

$2,090in general payments, 2019–2025

Across 112 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$317
  • Lilly USA, LLC$248
  • Novo Nordisk$243
  • Exact Sciences$207
  • Daiichi Sankyo Inc.$186
  • Pfizer$117
  • plus $772 from 17 others

What the payments were for

  • Food & beverage$2,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,090 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$37,339
Medicare patients
107
Services billed
542

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$55,682
JardianceEmpagliflozin35$55,527
TrulicityDulaglutide25$48,294
MounjaroTirzepatide23$46,425
JanuviaSitagliptin Phosphate21$32,643
EliquisApixaban25$21,911
RybelsusSemaglutide16$21,742
FarxigaDapagliflozin Propanediol16$16,505
XareltoRivaroxaban17$12,901
JanumetSitagliptin Phos/Metformin Hcl12$7,126
Gabapentin135$2,796
Albuterol Sulfate HfaAlbuterol Sulfate67$2,721
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen62$1,529
Atorvastatin Calcium191$1,513
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide31$1,491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$248$94,71848 claims
Novo NordiskOzempic, Rybelsus$243$77,42552 claims
Boehringer IngelheimJardiance$113$55,52735 claims
MerckJanuvia, Janumet$51$39,76933 claims
PfizerEliquis$117$21,91125 claims
AstraZenecaFarxiga$317$16,50516 claims
Johnson & JohnsonXarelto$57$12,90117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Locust Grove

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →